Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

AXSMAXSM
25 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in AXSOME THERAPEUTICS INC

Schonfeld Strategic Advisors LLC holds 35,608 shares of AXSM (AXSOME THERAPEUTICS INC), worth $8.7M as of 2026-Q2. This is a new position. AXSM represents 0.0% of Schonfeld Strategic Advisors LLC's portfolio.

Current Value

$8.7M

Current Shares

35,608

Total Value Change

+$6.9M

Total Shares Change

-88,892

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
35,608
-
$8.7M0.0%$244.77
38
2025-Q3
Exited
0
-100.0%
$00.0%$117.62
0
2025-Q2
Decreased
2,490
-89.7%
$259,9310.0%$103.36
0
2025-Q1
Decreased
24,200
-4.7%
$2.8M0.0%$118.53
0
2024-Q4
Decreased
25,380
-69.0%
$2.1M0.0%$84.78
0
2024-Q3
Increased
81,997
+39.2%
$7.4M0.0%$89.64
36
2024-Q2
Decreased
58,909
-2.1%
$4.7M0.0%$80.50
0
2024-Q1
Decreased
60,182
-43.7%
$4.8M0.0%$79.80
0
2023-Q4
Increased
106,842
+57.8%
$8.5M0.1%$79.59
39
2023-Q3
Decreased
67,698
-10.1%
$4.7M0.0%$69.89
0
2023-Q2
Increased
75,312
+630.3%
$5.4M0.0%$73.12
44
2023-Q1
Decreased
10,313
-87.8%
$636,1050.0%$60.55
0
2022-Q4
Increased
84,355
+70.8%
$6.5M0.1%$77.13
41
2022-Q3
Decreased
49,400
-0.5%
$2.2M0.0%$44.15
0
2022-Q2
Increased
49,624
+579.8%
$1.9M0.0%$36.49
42
2022-Q1
New
7,300
-
$302,0000.0%$40.02
32
2021-Q4
Exited
0
-100.0%
$00.0%$38.02
0
2021-Q3
New
1,317
-
$44,0000.0%$34.17
28
2020-Q3
Exited
0
-100.0%
$00.0%$72.28
0
2020-Q2
Increased
39,772
+215.2%
$3.3M0.0%$76.36
43
2020-Q1
Decreased
12,619
-58.2%
$742,0000.0%$57.58
0
2019-Q4
Decreased
30,188
-75.4%
$3.1M0.1%$103.83
0
2019-Q3
Decreased
122,500
-79.9%
$2.5M0.1%$22.09
0
2019-Q2
Increased
609,800
+389.8%
$15.7M0.6%$25.75
64
2019-Q1
New
124,500
-
$1.8M0.1%$14.23
36

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used